about
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubismIdentification of novel stem cell markers using gap analysis of gene expression data.Recent developments in StemBase: a tool to study gene expression in human and murine stem cells.Integration of expressed sequence tag data flanking predicted RNA secondary structures facilitates novel non-coding RNA discovery.Essential gene profiles in breast, pancreatic, and ovarian cancer cells.CaPSID: a bioinformatics platform for computational pathogen sequence identification in human genomes and transcriptomes.Study of stem cell function using microarray experiments.Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing.Computational approaches to discovering noncoding RNA.Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer.Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling.Regional perturbation of gene transcription is associated with intrachromosomal rearrangements and gene fusion transcripts in high grade ovarian cancerPlasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.Impact of Chemical-Induced Mutational Load Increase on Immune Checkpoint Therapy in Poorly Responsive Murine TumorsIntegration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in MetastasesCombined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinomaCryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing
P50
Q24299210-D1A9AFEE-9CE5-435C-8D8F-9A8EEC2A5573Q31129690-F4222A62-2D12-40B8-A3B8-B463C98CCB61Q33417842-15A242FA-FFDF-492A-93DF-1B9C3BEA52BAQ33941279-BE1AA80E-57A3-42B7-9C2C-B7E73F9C57DEQ34268870-E2FD2FC8-4D4F-431F-AB1D-88E5C9D603B8Q34383196-1462B95D-7E65-434B-BF27-07ED8B9025E4Q36069205-0D78C0E7-FAC5-49BD-964F-D47E03F747EEQ36295144-3DC87EF8-4961-42E4-8B4B-A0D50B4833E7Q38007394-672DB6D7-C93F-46B7-86F4-4AC421A27375Q38432788-4A0F589E-C87A-4CC7-B514-7348D4759594Q47232401-97FF648D-94B7-4B67-85E4-6C7DBC8AFE9AQ55470737-ECDBA725-3BCB-4327-BA2F-377B37BCE372Q64065374-B3AC1931-B50F-4FCF-AD63-2BC7A615BD66Q65002389-B7402B1B-67FF-4726-8720-230917707080Q87887766-5FC270FC-CB1E-45B2-9D32-6AC1B01E4085Q91241746-F30AEEAE-497D-4E2A-9420-56975BFF9C5EQ92697253-2E1F82B2-AC72-4974-BEE9-05807A2AB9F6Q92757949-B717C62B-B9AB-4B04-AE58-C2CB0E252C3F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Paul M Krzyzanowski
@en
Paul M Krzyzanowski
@nl
type
label
Paul M Krzyzanowski
@en
Paul M Krzyzanowski
@nl
prefLabel
Paul M Krzyzanowski
@en
Paul M Krzyzanowski
@nl
P31
P496
0000-0001-6430-5995